Delaware Chapter of the American College of CardiologyOur purpose is to contribute to the prevention of cardiovascular diseases, to ensure optimal quality of care for individuals with such diseases, and to foster the highest professional ethical standards. Please let us know what information you want to see here. Feel free to contact us with your ideas, needs and comments. |
|
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Latest in Cardiology from ACC.org
- Managing Cardiovascular Disease in Older Adults With Cognitive Impairment: Challenges and Practical StrategiesOlder adults with cardiovascular (CV) risk factors or established cardiovascular disease (CVD) are at increased risk of cognitive impairment (CI). This risk is observed across several conditions, including hypertension, atrial fibrillation (AF), heart failure, and coronary artery disease.
- Editors' Corner | The Ongoing Challenge of Tricuspid RegurgitationThis month's cover story offers a practical, concise review of contemporary care for patients with tricuspid regurgitation (TR). It synthesizes key lessons from clinical trials that now guide decision-making for direct tricuspid valve interventions.
- Cover Story | Tricuspid Valve Intervention: Clinical Decision-Making For Patient SelectionFor decades, cardiologists have referred to the tricuspid valve as "the forgotten valve." One reason for this neglect is that tricuspid regurgitation (TR) often goes unnoticed, explains Robert O. Bonow, MD, MACC, Distinguished Professor at Northwestern University Feinberg School of Medicine in Chicago, IL.
- Feature | Navigating Valve DiseaseShared decision-making has become central to the management of valve disease, including tricuspid regurgitation (TR) (see cover story) and severe aortic stenosis (AS). If done correctly, it can help clinicians engage patients and families in meaningful discussions about symptoms, prognosis, treatment burden and personal goals...
- Feature | Cardiovascular Device Safety Can't End at ImplantationModern cardiovascular care is dependent on safe and effective implanted devices. In the U.S., the cardiovascular care team implants between one and two million new devices each year. The cumulative total of implanted devices in our patients cannot be accurately estimated but is easily in the tens of millions.



